Literature DB >> 10581158

Recombinant soluble human CD69 dimer produced in Escherichia coli: reevaluation of saccharide binding.

R A Childs1, C Galustian, A M Lawson, G Dougan, K Benwell, G Frankel, T Feizi.   

Abstract

We reevaluate here an earlier report of monosaccharide binding by the C-type lectin-like, leukocyte surface protein CD69 in the form of a recombinant soluble dimer, and we examine polysaccharide binding by the protein. We have expressed in Escherichia coli a new construct of the extracellular part (Q(65)-K(199)) of human CD69. We describe the folding in vitro to produce, in good yield, the protein in a soluble, disulphide-linked, dimeric form, and the results of binding experiments with monosaccharides: glucose, galactose, mannose, fucose, N-acetylglucosamine, and N-acetylgalactosamine, linked to bovine serum albumin. Monosaccharide-binding signals are not detectable. Among the polysaccharides, heparin, chondroitin sulphates A, B, and C, fucoidan, and dextran sulphate, CD69 dimer gives a weak binding signal with fucoidan. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10581158     DOI: 10.1006/bbrc.1999.1762

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Progress in deciphering the information content of the 'glycome'--a crescendo in the closing years of the millennium.

Authors:  T Feizi
Journal:  Glycoconj J       Date:  2000 Jul-Sep       Impact factor: 2.916

2.  Re-evaluation of binding properties of recombinant lymphocyte receptors NKR-P1A and CD69 to chemically synthesized glycans and peptides.

Authors:  Daniel Rozbeský; Jana Krejzová; Karel Křenek; Jan Prchal; Richard Hrabal; Milan Kožíšek; Lenka Weignerová; Michele Fiore; Pascal Dumy; Vladimír Křen; Olivier Renaudet
Journal:  Int J Mol Sci       Date:  2014-01-17       Impact factor: 5.923

Review 3.  CD69 is the crucial regulator of intestinal inflammation: a new target molecule for IBD treatment?

Authors:  Katarina Radulovic; Jan Hendrik Niess
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.